Podcast
Questions and Answers
What is the primary risk factor for coronary heart disease related to plasma cholesterol levels?
What is the primary risk factor for coronary heart disease related to plasma cholesterol levels?
- Stable plasma cholesterol concentrations
- Elevated plasma LDL-cholesterol levels (correct)
- Decreased plasma triglycerides
- High HDL-cholesterol levels
Which type of studies provide unequivocal evidence of the relationship between coronary atherosclerosis and plasma cholesterol concentrations?
Which type of studies provide unequivocal evidence of the relationship between coronary atherosclerosis and plasma cholesterol concentrations?
- Qualitative reviews
- Animal studies
- Epidemiological studies (correct)
- Case studies
What is NOT one of the major sources of cholesterol in the human body?
What is NOT one of the major sources of cholesterol in the human body?
- Bacterial fermentation (correct)
- Transport via lipoprotein particles
- Synthesis in the liver
- Dietary intake
What key feature enables lipoprotein particles to transport cholesterol in the blood?
What key feature enables lipoprotein particles to transport cholesterol in the blood?
Which of the following pathways is NOT involved in cholesterol transport and metabolism?
Which of the following pathways is NOT involved in cholesterol transport and metabolism?
Which class of drugs is primarily used to lower plasma cholesterol levels?
Which class of drugs is primarily used to lower plasma cholesterol levels?
What is the main mechanism of action of plasma cholesterol-lowering agents?
What is the main mechanism of action of plasma cholesterol-lowering agents?
Which of the following statements about the relationship between cholesterol and cardiovascular disease (CVD) is correct?
Which of the following statements about the relationship between cholesterol and cardiovascular disease (CVD) is correct?
What is the primary role of cholesterol in the human body?
What is the primary role of cholesterol in the human body?
Which of the following is NOT a source of cholesterol in the human body?
Which of the following is NOT a source of cholesterol in the human body?
How are cholesterol and related lipids transported in the bloodstream?
How are cholesterol and related lipids transported in the bloodstream?
Which apolipoprotein is primarily involved in mediating the uptake of remnant particles?
Which apolipoprotein is primarily involved in mediating the uptake of remnant particles?
What function does ApoB-100 serve in lipid metabolism?
What function does ApoB-100 serve in lipid metabolism?
Which statement correctly describes apolipoproteins?
Which statement correctly describes apolipoproteins?
What component makes up the inner core of lipoprotein particles?
What component makes up the inner core of lipoprotein particles?
Where in the body is cholesterol synthesized endogenously?
Where in the body is cholesterol synthesized endogenously?
What is the primary function of bile acids in relation to cholesterol?
What is the primary function of bile acids in relation to cholesterol?
Which lipoprotein carrier is found in chylomicrons?
Which lipoprotein carrier is found in chylomicrons?
What is the primary mechanism by which statins lower LDL-C levels?
What is the primary mechanism by which statins lower LDL-C levels?
Fibrates primarily exert their effects by activating which receptor?
Fibrates primarily exert their effects by activating which receptor?
What effect do fibrates have on triglyceride levels?
What effect do fibrates have on triglyceride levels?
Which of the following is an adverse effect associated with nicotinic acid?
Which of the following is an adverse effect associated with nicotinic acid?
How does ezetimibe function to regulate cholesterol levels?
How does ezetimibe function to regulate cholesterol levels?
Which class of drugs increases LDL-C clearance from circulation through the inhibition of PCSK9?
Which class of drugs increases LDL-C clearance from circulation through the inhibition of PCSK9?
What is a common adverse effect of both statins and nicotinic acid?
What is a common adverse effect of both statins and nicotinic acid?
Which of the following best describes the role of bempedoic acid in lipid regulation?
Which of the following best describes the role of bempedoic acid in lipid regulation?
Which drug class is primarily responsible for reducing plasma triglyceride levels through mediating effects on VLDL?
Which drug class is primarily responsible for reducing plasma triglyceride levels through mediating effects on VLDL?
What effect does mipomersen have on cholesterol regulation?
What effect does mipomersen have on cholesterol regulation?
Statins have secondary beneficial effects that include all EXCEPT which of the following?
Statins have secondary beneficial effects that include all EXCEPT which of the following?
Which adverse effect is commonly associated with the use of statins?
Which adverse effect is commonly associated with the use of statins?
Which of the following statements regarding PCSK9 is TRUE?
Which of the following statements regarding PCSK9 is TRUE?
How does lomitapide function in lipid regulation?
How does lomitapide function in lipid regulation?
What is the primary function of ApoC-II in the lipid metabolism process?
What is the primary function of ApoC-II in the lipid metabolism process?
Which pathway is responsible for the transport of dietary cholesterol and triglycerides from the intestine into the bloodstream?
Which pathway is responsible for the transport of dietary cholesterol and triglycerides from the intestine into the bloodstream?
What component is mainly responsible for the formation of mature HDL from nascent HDL?
What component is mainly responsible for the formation of mature HDL from nascent HDL?
The remnants of chylomicrons are removed from the plasma primarily through which receptor in the liver?
The remnants of chylomicrons are removed from the plasma primarily through which receptor in the liver?
What is the consequence of bile acid sequestrants on hepatic cholesterol levels?
What is the consequence of bile acid sequestrants on hepatic cholesterol levels?
Which agent is primarily involved in the hydrolysis of triglycerides in chylomicrons?
Which agent is primarily involved in the hydrolysis of triglycerides in chylomicrons?
What role does ApoA-I play in the metabolism of HDL particles?
What role does ApoA-I play in the metabolism of HDL particles?
Which process is involved in returning excess cholesterol from peripheral tissues to the liver?
Which process is involved in returning excess cholesterol from peripheral tissues to the liver?
How do VLDL particles contribute to lipid metabolism?
How do VLDL particles contribute to lipid metabolism?
What primarily initiates the absorption of dietary cholesterol in enterocytes?
What primarily initiates the absorption of dietary cholesterol in enterocytes?
Which lipoprotein class is considered potentially pro-atherogenic?
Which lipoprotein class is considered potentially pro-atherogenic?
What effect do bile acid sequestrants have on triglyceride levels?
What effect do bile acid sequestrants have on triglyceride levels?
How does cholesterol get esterified in enterocytes post absorption?
How does cholesterol get esterified in enterocytes post absorption?
What is the consequence of hepatic lipase action on intermediate-density lipoproteins (IDL)?
What is the consequence of hepatic lipase action on intermediate-density lipoproteins (IDL)?
What condition is NOT categorized as a type of cardiovascular disease?
What condition is NOT categorized as a type of cardiovascular disease?
What is the primary aim when optimizing lipids in a patient?
What is the primary aim when optimizing lipids in a patient?
Which of the following statements about lipids is accurate?
Which of the following statements about lipids is accurate?
Which of the following is a key understanding related to QRISK assessments?
Which of the following is a key understanding related to QRISK assessments?
What is a common condition associated with atherosclerosis?
What is a common condition associated with atherosclerosis?
Which of the following best describes the term 'lipoproteins'?
Which of the following best describes the term 'lipoproteins'?
What is NOT a strategy for reducing the risk of cardiovascular disease?
What is NOT a strategy for reducing the risk of cardiovascular disease?
Which statement is false regarding cardiovascular disease prevention?
Which statement is false regarding cardiovascular disease prevention?
In which scenario would a patient be indicated for secondary prevention due to severe hypercholesterolaemia?
In which scenario would a patient be indicated for secondary prevention due to severe hypercholesterolaemia?
What characterizes a very high-risk patient concerning cardiovascular events?
What characterizes a very high-risk patient concerning cardiovascular events?
What could be the likely outcome for a patient with normal U&Es, LFTs, TFTs, HbA1c, and urine:albumin but elevated LDL-C of 4.4mmol/L?
What could be the likely outcome for a patient with normal U&Es, LFTs, TFTs, HbA1c, and urine:albumin but elevated LDL-C of 4.4mmol/L?
Which of the following factors contributes to classifying a patient as high risk for hypercholesterolaemia?
Which of the following factors contributes to classifying a patient as high risk for hypercholesterolaemia?
Which lipid profile result indicates a need for further evaluation or treatment in a patient with optimal lifestyle and no family history of elevated cholesterol?
Which lipid profile result indicates a need for further evaluation or treatment in a patient with optimal lifestyle and no family history of elevated cholesterol?
What is the primary purpose of atorvastatin in primary prevention?
What is the primary purpose of atorvastatin in primary prevention?
What is the recommended monitoring period before repeating a lipid panel for patients on atorvastatin?
What is the recommended monitoring period before repeating a lipid panel for patients on atorvastatin?
What should be assessed prior to initiating atorvastatin treatment?
What should be assessed prior to initiating atorvastatin treatment?
If a patient on atorvastatin experiences elevated liver function tests, when should the tests be repeated?
If a patient on atorvastatin experiences elevated liver function tests, when should the tests be repeated?
What is a key lifestyle modification encouraged alongside atorvastatin therapy?
What is a key lifestyle modification encouraged alongside atorvastatin therapy?
How often should liver function tests be monitored once atorvastatin treatment has stabilized?
How often should liver function tests be monitored once atorvastatin treatment has stabilized?
What is the primary role of triglycerides in the body?
What is the primary role of triglycerides in the body?
What action should be taken if a patient's creatine kinase level is over 5 times the upper limit during atorvastatin treatment?
What action should be taken if a patient's creatine kinase level is over 5 times the upper limit during atorvastatin treatment?
Which component is assessed in a standard lipid profile?
Which component is assessed in a standard lipid profile?
What is the target percentage reduction in non-HDL cholesterol when on atorvastatin?
What is the target percentage reduction in non-HDL cholesterol when on atorvastatin?
In the context of patient assessment, what does a QRISK score above 10% indicate?
In the context of patient assessment, what does a QRISK score above 10% indicate?
What factors could potentially impact the accuracy of QRISK assessment?
What factors could potentially impact the accuracy of QRISK assessment?
Which of the following best describes cholesterol's role in the body?
Which of the following best describes cholesterol's role in the body?
At what point might a QRISK assessment need to be reset?
At what point might a QRISK assessment need to be reset?
What is the significance of a cholesterol: HDL ratio of 5?
What is the significance of a cholesterol: HDL ratio of 5?
Which of the following health conditions is NOT mentioned as a factor influencing cholesterol levels?
Which of the following health conditions is NOT mentioned as a factor influencing cholesterol levels?
What should be done if a patient on atorvastatin 80mg does not achieve a 40% reduction in lipids?
What should be done if a patient on atorvastatin 80mg does not achieve a 40% reduction in lipids?
What is a significant side effect associated with statin use that warrants discontinuation of the drug?
What is a significant side effect associated with statin use that warrants discontinuation of the drug?
What is the recommended action when a patient taking rosuvastatin is prescribed clarithromycin?
What is the recommended action when a patient taking rosuvastatin is prescribed clarithromycin?
What should be monitored during statin therapy to assess lipid control?
What should be monitored during statin therapy to assess lipid control?
Which statement is true regarding statin administration and sleep disturbances?
Which statement is true regarding statin administration and sleep disturbances?
Which adverse effect is most commonly shared between statins and ezetimibe?
Which adverse effect is most commonly shared between statins and ezetimibe?
What monitoring is critical for patients on statins to prevent toxicity?
What monitoring is critical for patients on statins to prevent toxicity?
What action is recommended if a patient experiences muscle pain while on statin therapy?
What action is recommended if a patient experiences muscle pain while on statin therapy?
What is the recommended dosage of atorvastatin for patients with established cardiovascular disease?
What is the recommended dosage of atorvastatin for patients with established cardiovascular disease?
Inclisiran is licensed for which group of patients?
Inclisiran is licensed for which group of patients?
What is the primary goal of high-dose statin therapy in secondary prevention?
What is the primary goal of high-dose statin therapy in secondary prevention?
Which action is necessary for patients undergoing treatment with injectable PCSK9 inhibitors?
Which action is necessary for patients undergoing treatment with injectable PCSK9 inhibitors?
What is a key component of discussing ASCVD risk reduction with patients?
What is a key component of discussing ASCVD risk reduction with patients?
Which of the following treatments might be considered if non-HDL-C levels exceed 2.6mmol/L after statin therapy?
Which of the following treatments might be considered if non-HDL-C levels exceed 2.6mmol/L after statin therapy?
What monitoring is emphasized for patients on lipid-modifying therapy?
What monitoring is emphasized for patients on lipid-modifying therapy?
What is a consequence of drug interactions with grapefruit juice for patients on certain lipid-lowering medications?
What is a consequence of drug interactions with grapefruit juice for patients on certain lipid-lowering medications?
What is a critical component of a shared management plan for patients at risk of ASCVD?
What is a critical component of a shared management plan for patients at risk of ASCVD?
Flashcards
Cholesterol & CVD
Cholesterol & CVD
Atherosclerosis and coronary events are strongly connected to the amount of cholesterol in the blood. This relationship has been confirmed through various studies.
What is LDL-cholesterol?
What is LDL-cholesterol?
It is a major risk factor for coronary heart disease. High levels of this type of cholesterol in the blood are directly linked to heart problems.
Major Studies Linking Cholesterol and CVD
Major Studies Linking Cholesterol and CVD
The Framingham Heart Study and the MRFIT are two major studies that have provided substantial evidence linking cholesterol levels to heart disease.
How Do Genetic Studies Support the Link?
How Do Genetic Studies Support the Link?
Signup and view all the flashcards
What is Cholesterol?
What is Cholesterol?
Signup and view all the flashcards
What is Cholesterol Metabolism?
What is Cholesterol Metabolism?
Signup and view all the flashcards
What are Plasma Lipid Lowering Agents?
What are Plasma Lipid Lowering Agents?
Signup and view all the flashcards
Key Types of Cholesterol Lowering Agents
Key Types of Cholesterol Lowering Agents
Signup and view all the flashcards
Cholesterol
Cholesterol
Signup and view all the flashcards
Exogenous Cholesterol
Exogenous Cholesterol
Signup and view all the flashcards
Endogenous Cholesterol
Endogenous Cholesterol
Signup and view all the flashcards
Endogenous Cholesterol Synthesis
Endogenous Cholesterol Synthesis
Signup and view all the flashcards
Lipoprotein Particles
Lipoprotein Particles
Signup and view all the flashcards
Hydrophobic Core
Hydrophobic Core
Signup and view all the flashcards
Hydrophilic Coat
Hydrophilic Coat
Signup and view all the flashcards
Apolipoproteins (Apo)
Apolipoproteins (Apo)
Signup and view all the flashcards
Lipoprotein Classification
Lipoprotein Classification
Signup and view all the flashcards
Low-Density Lipoprotein (LDL)
Low-Density Lipoprotein (LDL)
Signup and view all the flashcards
Intestinal Cholesterol Absorption
Intestinal Cholesterol Absorption
Signup and view all the flashcards
ApoE
ApoE
Signup and view all the flashcards
Lipoprotein Lipase (LPL)
Lipoprotein Lipase (LPL)
Signup and view all the flashcards
VLDL (Very Low-Density Lipoprotein)
VLDL (Very Low-Density Lipoprotein)
Signup and view all the flashcards
LDL (Low-Density Lipoprotein)
LDL (Low-Density Lipoprotein)
Signup and view all the flashcards
HDL (High-Density Lipoprotein)
HDL (High-Density Lipoprotein)
Signup and view all the flashcards
Reverse Cholesterol Transport
Reverse Cholesterol Transport
Signup and view all the flashcards
ApoA-I
ApoA-I
Signup and view all the flashcards
Niemann-Pick C1-Like 1 (NPC1L1)
Niemann-Pick C1-Like 1 (NPC1L1)
Signup and view all the flashcards
Lecithin:Cholesterol Acyltransferase (LCAT)
Lecithin:Cholesterol Acyltransferase (LCAT)
Signup and view all the flashcards
Scavenger Receptor, Class B, Type 1 (SR-B1)
Scavenger Receptor, Class B, Type 1 (SR-B1)
Signup and view all the flashcards
ApoC-II
ApoC-II
Signup and view all the flashcards
ApoC-III
ApoC-III
Signup and view all the flashcards
ApoB-100
ApoB-100
Signup and view all the flashcards
Hepatic Lipase (HL)
Hepatic Lipase (HL)
Signup and view all the flashcards
Exogenous Lipid Pathway
Exogenous Lipid Pathway
Signup and view all the flashcards
Endogenous Lipid Pathway
Endogenous Lipid Pathway
Signup and view all the flashcards
Statins
Statins
Signup and view all the flashcards
Nicotinic Acid
Nicotinic Acid
Signup and view all the flashcards
Ezetimibe
Ezetimibe
Signup and view all the flashcards
PCSK9
PCSK9
Signup and view all the flashcards
PCSK9 inhibitors
PCSK9 inhibitors
Signup and view all the flashcards
Selective Cholesterol absorption Inhibitors
Selective Cholesterol absorption Inhibitors
Signup and view all the flashcards
HMG-CoA reductase Inhibitors
HMG-CoA reductase Inhibitors
Signup and view all the flashcards
NSAIDs
NSAIDs
Signup and view all the flashcards
Warfarin
Warfarin
Signup and view all the flashcards
GIT disturbances
GIT disturbances
Signup and view all the flashcards
Thiazide diuretics
Thiazide diuretics
Signup and view all the flashcards
Digoxin
Digoxin
Signup and view all the flashcards
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Signup and view all the flashcards
Warfarin
Warfarin
Signup and view all the flashcards
Digoxin
Digoxin
Signup and view all the flashcards
What is Cardiovascular Disease?
What is Cardiovascular Disease?
Signup and view all the flashcards
What is Atherosclerosis?
What is Atherosclerosis?
Signup and view all the flashcards
What are Lipids?
What are Lipids?
Signup and view all the flashcards
What is Primary Prevention of CVD?
What is Primary Prevention of CVD?
Signup and view all the flashcards
What is Secondary Prevention of CVD?
What is Secondary Prevention of CVD?
Signup and view all the flashcards
What is a QRISK assessment?
What is a QRISK assessment?
Signup and view all the flashcards
What are other CVD conditions?
What are other CVD conditions?
Signup and view all the flashcards
Why optimize lipids?
Why optimize lipids?
Signup and view all the flashcards
What are triglycerides?
What are triglycerides?
Signup and view all the flashcards
What does a lipid profile measure?
What does a lipid profile measure?
Signup and view all the flashcards
Why is high cholesterol a risk factor for heart disease?
Why is high cholesterol a risk factor for heart disease?
Signup and view all the flashcards
What is primary prevention in heart disease?
What is primary prevention in heart disease?
Signup and view all the flashcards
What is QRISK3?
What is QRISK3?
Signup and view all the flashcards
What happens after a QRISK3 assessment?
What happens after a QRISK3 assessment?
Signup and view all the flashcards
What are some primary prevention treatments for heart disease?
What are some primary prevention treatments for heart disease?
Signup and view all the flashcards
High Risk Patient with High LDL-C
High Risk Patient with High LDL-C
Signup and view all the flashcards
Very High Risk Patient with High LDL-C
Very High Risk Patient with High LDL-C
Signup and view all the flashcards
Familial Hypercholesterolaemia
Familial Hypercholesterolaemia
Signup and view all the flashcards
Hypotriglyceridaemia
Hypotriglyceridaemia
Signup and view all the flashcards
Lipid Profile
Lipid Profile
Signup and view all the flashcards
Atorvastatin
Atorvastatin
Signup and view all the flashcards
Primary Prevention of CVD
Primary Prevention of CVD
Signup and view all the flashcards
Statin Monitoring
Statin Monitoring
Signup and view all the flashcards
Full Lipid Profile
Full Lipid Profile
Signup and view all the flashcards
Creatine Kinase
Creatine Kinase
Signup and view all the flashcards
Liver Function Deranged
Liver Function Deranged
Signup and view all the flashcards
Secondary Prevention of CVD
Secondary Prevention of CVD
Signup and view all the flashcards
40% Reduction in Non-HDL Cholesterol
40% Reduction in Non-HDL Cholesterol
Signup and view all the flashcards
What are high-dose statins?
What are high-dose statins?
Signup and view all the flashcards
What are PCSK9 inhibitors?
What are PCSK9 inhibitors?
Signup and view all the flashcards
What is ezetimibe?
What is ezetimibe?
Signup and view all the flashcards
What is inclisiran?
What is inclisiran?
Signup and view all the flashcards
What is Atorvastatin?
What is Atorvastatin?
Signup and view all the flashcards
What is shared management in ASCVD risk reduction?
What is shared management in ASCVD risk reduction?
Signup and view all the flashcards
What are statins?
What are statins?
Signup and view all the flashcards
What is Enzyme Inhibition?
What is Enzyme Inhibition?
Signup and view all the flashcards
What is myopathy?
What is myopathy?
Signup and view all the flashcards
What are sleep disturbances?
What are sleep disturbances?
Signup and view all the flashcards
What is key statin counselling?
What is key statin counselling?
Signup and view all the flashcards
What are statin interactions?
What are statin interactions?
Signup and view all the flashcards
What are food interactions with statins?
What are food interactions with statins?
Signup and view all the flashcards
Study Notes
MPharm Programme: Plasma Lipid (Cholesterol) Transport & Metabolism
- This week's programme focuses on plasma lipid (cholesterol) transport and metabolism.
- The lecturer is Dr G Boachie-Ansah, with contact details provided.
- The course material covers cardiovascular disease (CVD) pathogenesis, cholesterol metabolism and transport, and current plasma lipid-lowering drugs and their mechanisms of action.
General Outline of Lecture
- The established role of cholesterol in cardiovascular disease (CVD) pathogenesis.
- General overview of cholesterol metabolism and transport in the human body.
- Available plasma lipid-lowering drugs and their mechanisms of action.
Learning Outcomes
- Students should be able to describe the evidence base for cholesterol's central role in CVD pathogenesis.
- Students should be able to describe the structure of lipoprotein particles and their cholesterol transport in the blood.
- Students should be able to describe the sources of cholesterol and the three pathways of cholesterol transport and metabolism.
- Students should be able to name the major classes of plasma cholesterol-lowering agents and describe their mechanisms of action.
Plasma Cholesterol & CVD Risk
- Elevated plasma LDL-cholesterol levels are a major risk factor for coronary heart disease.
- Strong relationship between coronary atherosclerosis, coronary events, and plasma cholesterol concentrations, supported by epidemiological and genetic studies, as well as experimental and clinical trials.
- Management of plasma cholesterol levels is a crucial component of cardiovascular disease prevention.
Why Do Humans Need Cholesterol?
- Cholesterol is crucial for synthesizing cell membranes, stabilizing and transporting functions.
- Also required for steroid hormones (e.g., adrenal and sex hormones).
- It's a component for bile acids, facilitating the gastrointestinal absorption of dietary fat.
Major Sources of Cholesterol
- Exogenous: Dietary intake (e.g., eggs, shellfish).
- Endogenous: De novo synthesis in various organs and tissues (e.g., liver, intestines, ovaries, adrenals).
Cholesterol Transport
- Cholesterol and related lipids are insoluble in water, requiring transport as water-soluble lipoprotein particles.
- Lipoproteins have a hydrophobic core (e.g., cholesterol, cholesterol esters, triglycerides, free fatty acids) and a hydrophilic coat (apolipoproteins, phospholipids, cholesterol).
Apolipoproteins
- Multiple isoforms (ApoA, ApoB, ApoC, ApoE,etc).
- Key functions: lipoprotein assembly and transport in the blood, maintenance of lipoprotein structural integrity, enzyme activation and inhibition, and cellular receptor binding.
Classification of Lipoproteins
- Lipoproteins are classified based on their density (e.g. Chylomicrons, VLDL, IDL, LDL, HDL)
- Each class has specific lipid compositions and apolipoproteins with different functions. A table gives the source and key components of these lipoproteins.
Pathways of Plasma Lipid Transport and Metabolism
- Three major pathways: exogenous (intestinal), endogenous (hepatic), and reverse cholesterol transport.
- These pathways are co-ordinated by the liver to maintain a balance of major lipid classes.
Exogenous (Intestinal) Pathway
- Dietary & biliary cholesterol is absorbed into enterocytes via NPC1L1 transporter.
- Absorbed cholesterol is esterified by ACAT.
- Esterified cholesterol packaged into chylomicrons (CMs) by MTP.
- Triglycerides in CMs leave the intestine via lymphatics, enter the bloodstream.
- Endothelial lipoprotein lipase (LPL) hydrolyzes triglycerides in CMs releasing free fatty acids (FFAs) utilised for energy or stored as fat.
- Chylomicron remnants are removed by the liver via apoE binding to the LRP or LDL receptor (LDLR).
- This pathway is mainly for dietary lipids.
Endogenous (Hepatic) Pathway
- Cholesterol synthesis and transport in the liver.
- Chylomicron remnants are taken up by hepatocytes.
- They are re-packaged into VLDL particles to transport endogenous lipids.
- Triglycerides in VLDL are hydrolyzed by LPL releasing FFAs for energy or storage.
- IDL formed.
- IDL taken up by liver or converted into LDL.
- LDL carries cholesterol to peripheral tissues.
- Excess LDL cholesterol is removed from the circulation by the liver, either directly or indirectly through exchange with other lipoproteins.
Reverse Cholesterol Transport
- Excess LDL-C from peripheral cells is returned to the liver via HDL pathway.
- Nascent HDL picks up cholesterol from the cells.
- LCAT converts cholesterol to cholesteryl ester (CE) forming mature HDL.
- HDL transports CE to the liver.
- Direct (SR-B1) and indirect (CETP) mechanisms are used for HDL cholesterol transport to the liver.
Lipoprotein Classes and Atherogenesis
- ApoB-containing lipoproteins (chylomicrons, VLDL, LDL) are potentially pro-atherogenic.
- ApoA-I-containing lipoproteins (HDL) are potentially anti-atherogenic.
Plasma Lipid Regulating Drugs
-
First Generation Agents
- Bile acid sequestrants: non-absorbable resins (e.g., colestyramine, colesevelam) bind bile acids decreasing enterohepatic cycling, leading to increased hepatic cholesterol uptake and lowering LDL-C (15-30%), and modestly increasing HDL-C (3-5%). Adverse effects include GI disturbances and drug interactions (e.g., inhibits absorption of fat-soluble vitamins and some drugs).
- Fibric acid derivatives: (e.g., fenofibrate, gemfibrozil) increase lipoprotein lipase activity leading to TG hydrolysis and VLDL elimination, and they increase HDL activity. Adverse effects include drug interactions (e.g., statins → risk of myositis, and warfarin → ↑ anticoagulant effect) and GI disturbances (e.g., nausea, vomiting, dyspepsia, bloating, flatulence, constipation, cramping), and CNS effects (e.g., fatigue, headaches).
- Nicotinic Acid: (e.g., nicotinic acid, acipimox) reduces FFA mobilization, lowers TG synthesis and VLDL secretion lowering plasma LDL. Adverse effects include drug interactions (e.g., vasodilators → ↑ risk of hypotension, and statins → ↑ risk of myositis), flushing, and hepatotoxicity.
-
Second Generation Agents
- Statins: (e.g., lovastatin, simvastatin, pravastatin, atorvastatin, fluvastatin) inhibit HMG-CoA reductase, reducing hepatic cholesterol synthesis, and increasing LDL receptors resulting in clearing cholesterol from circulation. May have other benefits, such as anti-inflammatory effects. Potential for myalgia, myopathy, or rhabdomyolysis.
- Selective cholesterol absorption inhibitors (e.g., ezetimibe) inhibit intestinal cholesterol absorption into enterocytes, leading to reduced intestinal delivery to the liver.
-
Newer Agents
- PCSK9 inhibitors: (e.g., alirocumab, evolocumab) bind and inhibit PCSK9, increase recycling and expression of hepatic LDL receptors, and thus increase LDL clearance, resulting in lower plasma LDL-C (~50-60%).
- RNA interferences: (e.g., inclisiran) are small RNA molecules that target mRNA translation for PCSK9, thus lowering the synthesis of PCSK9, increasing LDL receptor recycling and expression, leading to a reduction in plasma LDL (~LDL-C 50-60%).
- Apolipoprotein B inhibitors: (e.g., mipomersen) reduce LDL cholesterol through a reduction in apoB-100 synthesis and VLDL production. Adverse effects may include decreased uptake, cleavage, and degradation of mRNA.
- ATP-citrate lyase (ACL) inhibitors (e.g., bempedoic acid): target ATP-citrate lyase, ultimately reducing hepatic cholesterol biosynthesis.
- Microsomal triglyceride transfer protein (MTP) inhibitors (e.g., lomitapide): reduce VLDL production.
Recommended Reading
- Zodda D et al. (2018). Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs. Pharmacy 6(1), 10. doi: 10.3390/pharmacy6010010.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
Test your knowledge on cholesterol's role in coronary heart disease and cardiovascular health. This quiz covers major sources of cholesterol, pathways of transport, and the impact of drugs on cholesterol levels. Understand the complex relationship between cholesterol and heart-related conditions.